← All medicines

Stomach and digestion

Ranitidine — reformulated-product context

Independent educational summary · Sources checked November 20, 2026

An H2 blocker for specified acid-related conditions. Earlier products were removed for impurity concerns; FDA approved reformulated tablets in November 2025.

Profile scope: Ranitidine — reformulated-product context. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Headache or digestive symptoms may occur.

Serious risks and warning signs

Do not treat the older withdrawal as proof that every newer product has the same impurity problem. Follow the current product's storage and handling label, including its after-opening limit. Seek advice for unexpected or severe symptoms; this brief source list does not establish zero serious risk.

A question for your healthcare team

Can we confirm that this is a currently approved product and review its storage, opening date, and suitability?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.